Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-16-000094
Filing Date
2016-09-13
Accepted
2016-09-13 17:08:20
Documents
62
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K panther_10k-053116.htm 10-K 564603
2 CERTICATION panther_10k-ex3101.htm EX-31.1 7953
3 CERTICATION panther_10k-ex3102.htm EX-31.2 8050
4 CERTICATION panther_10k-ex3201.htm EX-32.1 4509
  Complete submission text file 0001683168-16-000094.txt   2816740

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pbya-20160531.xml EX-101.INS 406297
6 XBRL SCHEMA FILE pbya-20160531.xsd EX-101.SCH 33565
7 XBRL CALCULATION FILE pbya-20160531_cal.xml EX-101.CAL 48904
8 XBRL DEFINITION FILE pbya-20160531_def.xml EX-101.DEF 83596
9 XBRL LABEL FILE pbya-20160531_lab.xml EX-101.LAB 227163
10 XBRL PRESENTATION FILE pbya-20160531_pre.xml EX-101.PRE 188422
Mailing Address 888 PROSPECT STREET LA JOLLA CA 92037
Business Address 888 PROSPECT STREET LA JOLLA CA 92037 (858) 263-2744
PANTHER BIOTECHNOLOGY, INC. (Filer) CIK: 0001530981 (see all company filings)

EIN.: 331221758 | State of Incorp.: NV | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-55074 | Film No.: 161883426
SIC: 8700 Services-Engineering, Accounting, Research, Management